{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:10:48Z","timestamp":1770275448208,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"DOI":"10.7759\/cureus.102971","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:59:54Z","timestamp":1770224394000},"source":"Crossref","is-referenced-by-count":0,"title":["Closing the Osteoporosis Care Gap: System-Level Fracture Liaison Service Implementation and a Patient Education Intervention in an Open Health System"],"prefix":"10.7759","author":[{"given":"Kathleena","family":"D'Anna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasam","family":"Alfraji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artem","family":"Minalyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Downey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Osteoporosis or low bone mass in older adults: United States, 2017-2018","author":"Sarafrazi N","year":"2021","unstructured":"Sarafrazi N, Wambogo EA, Shepherd JA. Osteoporosis or low bone mass in older adults: United States, 2017-2018. NCHS Data Brief, no 405. National Center for Health Statistics, Hyattsville, MD; 2021. 1-8."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.01.012","article-title":"Drug discovery of sclerostin inhibitors","volume":"12","author":"Yu S","year":"2022","unstructured":"Yu S, Li D, Zhang N, et al.. Drug discovery of sclerostin inhibitors. Acta Pharm Sin B. 2022, 12:2150-70. 10.1016\/j.apsb.2022.01.012","journal-title":"Acta Pharm Sin B"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5114\/pm.2016.65682","article-title":"How can gynaecologists cope with the silent killer - osteoporosis?","volume":"15","author":"Szamatowicz M","year":"2016","unstructured":"Szamatowicz M. How can gynaecologists cope with the silent killer - osteoporosis?. Prz Menopauzalny. 2016, 15:189-92. 10.5114\/pm.2016.65682","journal-title":"Prz Menopauzalny"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"S\u00f6zen T","year":"2017","unstructured":"S\u00f6zen T, \u00d6z\u0131\u015f\u0131k L, Ba\u015faran N\u00c7. An overview and management of osteoporosis. Eur J Rheumatol. 2017, 4:46-56. 10.5152\/eurjrheum.2016.048","journal-title":"Eur J Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-019-1226-6","article-title":"Mortality after osteoporotic hip fracture: incidence, trends, and associated factors","volume":"14","author":"Guzon-Illescas O","year":"2019","unstructured":"Guzon-Illescas O, Perez Fernandez E, Cresp\u00ed Villarias N, et al.. Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res. 2019, 14:203. 10.1186\/s13018-019-1226-6","journal-title":"J Orthop Surg Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.38393","article-title":"Antiosteoporosis medication prescriptions after fragility fractures","volume":"7","author":"Silverstein WK","year":"2024","unstructured":"Silverstein WK, Wang S, Alavinejad M, et al.. Antiosteoporosis medication prescriptions after fragility fractures. JAMA Netw Open. 2024, 7:e2438393. 10.1001\/jamanetworkopen.2024.38393","journal-title":"JAMA Netw Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.N.01275","article-title":"Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample","volume":"97","author":"Bawa HS","year":"2015","unstructured":"Bawa HS, Weick J, Dirschl DR. Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am. 2015, 97:1555-62. 10.2106\/JBJS.N.01275","journal-title":"J Bone Joint Surg Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-17-00103","article-title":"Recurrent fragility fractures: a cross-sectional analysis","volume":"27","author":"Dang DY","year":"2019","unstructured":"Dang DY, Zetumer S, Zhang AL. Recurrent fragility fractures: a cross-sectional analysis. J Am Acad Orthop Surg. 2019, 27:e85-91. 10.5435\/JAAOS-D-17-00103","journal-title":"J Am Acad Orthop Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3443-0","article-title":"Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate","volume":"27","author":"Nakayama A","year":"2016","unstructured":"Nakayama A, Major G, Holliday E, Attia J, Bogduk N. Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int. 2016, 27:873-9. 10.1007\/s00198-015-3443-0","journal-title":"Osteoporos Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac508","article-title":"Inpatient zoledronic acid and integrated orthopedic and fracture liaison services improve osteoporosis treatment rates","volume":"108","author":"Fan W","year":"2022","unstructured":"Fan W, Machado M, Leder BZ, et al.. Inpatient zoledronic acid and integrated orthopedic and fracture liaison services improve osteoporosis treatment rates. J Clin Endocrinol Metab. 2022, 108:191-7. 10.1210\/clinem\/dgac508","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-023-08568-8","article-title":"Lessons learned: evaluation of fracture liaison service quality improvement efforts in a large academic healthcare system","volume":"39","author":"Billups SJ","year":"2024","unstructured":"Billups SJ, Fixen DR, Schilling LM, El-Sheikh A, Marcus AM, Rothman MS. Lessons learned: evaluation of fracture liaison service quality improvement efforts in a large academic healthcare system. J Gen Intern Med. 2024, 39:1407-13. 10.1007\/s11606-023-08568-8","journal-title":"J Gen Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07557-3","article-title":"Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up","volume":"36","author":"Demers AJ","year":"2025","unstructured":"Demers AJ, Fitton LS, McCulley SM, et al.. Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up. Osteoporos Int. 2025, 36:1379-90. 10.1007\/s00198-025-07557-3","journal-title":"Osteoporos Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2023.110985","article-title":"Intradepartmental orthopaedic fragility fracture liaison improves osteoporosis follow-up and treatment","volume":"54","author":"Galasso AC","year":"2023","unstructured":"Galasso AC, Herzog LN, Sekar M, Hartsock LA, Reid KR. Intradepartmental orthopaedic fragility fracture liaison improves osteoporosis follow-up and treatment. Injury. 2023, 54:110985. 10.1016\/j.injury.2023.110985","journal-title":"Injury"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1712-0","article-title":"Fracture prevention in Kaiser Permanente Southern California","volume":"22 Suppl 3","author":"Dell R","year":"2011","unstructured":"Dell R. Fracture prevention in Kaiser Permanente Southern California. Osteoporos Int. 2011, 22 Suppl 3:457-60. 10.1007\/s00198-011-1712-0","journal-title":"Osteoporos Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v11i1.3481","article-title":"Geisinger high-risk osteoporosis clinic: narrowing post-fracture care gaps and lessons learned","volume":"11","author":"Olenginski TP","year":"2023","unstructured":"Olenginski TP. Geisinger high-risk osteoporosis clinic: narrowing post-fracture care gaps and lessons learned. Medical Res Arch. 2023, 11:1-16. 10.18103\/mra.v11i1.3481","journal-title":"Medical Res Arch"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04796-8","article-title":"The Fracture Liaison Service to close the osteoporosis care gap: a leadership educational model for undergraduate and postgraduate trainees","volume":"39","author":"Yu M","year":"2020","unstructured":"Yu M, Downey C, Torralba KD. The Fracture Liaison Service to close the osteoporosis care gap: a leadership educational model for undergraduate and postgraduate trainees. Clin Rheumatol. 2020, 39:619-26. 10.1007\/s10067-019-04796-8","journal-title":"Clin Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/sja.sja_545_23","article-title":"STROBE, CONSORT, PRISMA, MOOSE, STARD, SPIRIT, and other guidelines - overview and application","volume":"18","author":"Grech V","year":"2024","unstructured":"Grech V, Eldawlatly AA. STROBE, CONSORT, PRISMA, MOOSE, STARD, SPIRIT, and other guidelines - overview and application. Saudi J Anaesth. 2024, 18:137-41. 10.4103\/sja.sja_545_23","journal-title":"Saudi J Anaesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219681","article-title":"Osteoporosis prevention: where are the barriers to improvement in French general practitioners? A qualitative study","volume":"14","author":"Merle B","year":"2019","unstructured":"Merle B, Haesebaert J, Bedouet A, Barraud L, Flori M, Schott AM, Dupraz C. Osteoporosis prevention: where are the barriers to improvement in French general practitioners? A qualitative study. PLoS One. 2019, 14:e0219681. 10.1371\/journal.pone.0219681","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160661","article-title":"Managing osteoporosis: a survey of knowledge, attitudes and practices among primary care physicians in Israel","volume":"11","author":"Fogelman Y","year":"2016","unstructured":"Fogelman Y, Goldshtein I, Segal E, Ish-Shalom S. Managing osteoporosis: a survey of knowledge, attitudes and practices among primary care physicians in Israel. PLoS One. 2016, 11:e0160661. 10.1371\/journal.pone.0160661","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.6003","article-title":"Osteoporosis: a review","volume":"334","author":"Morin SN","year":"2025","unstructured":"Morin SN, Leslie WD, Schousboe JT. Osteoporosis: a review. JAMA. 2025, 334:894-907. 10.1001\/jama.2025.6003","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4409","article-title":"Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial","volume":"36","author":"Brown JP","year":"2021","unstructured":"Brown JP, Engelke K, Keaveny TM, et al.. Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial. J Bone Miner Res. 2021, 36:2139-52. 10.1002\/jbmr.4409","journal-title":"J Bone Miner Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag KG","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, et al.. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017, 377:1417-27. 10.1056\/NEJMoa1708322","journal-title":"N Engl J Med"},{"key":"ref23","unstructured":"Reduce hip fractures among older adults\u2014 O-02 Data. (2025). Accessed. September 18, 2025: https:\/\/odphp.health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/osteoporosis\/reduce-hip-fractures-among-...."},{"key":"ref24","unstructured":"Osteoporosis Management In Women Who Had a Fracture (OMW). (2025). Accessed. September 18, 2025: https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/osteoporosis-management-in-women-w...."},{"key":"ref25","unstructured":"2025 MIPS Measure #418. Osteoporosis Management in Women Who Had a Fracture. (2025). Accessed: September 18, 2025: https:\/\/mdinteractive.com\/mips_quality_measure\/2025-mips-quality-measure-418."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421691-closing-the-osteoporosis-care-gap-system-level-fracture-liaison-service-implementation-and-a-patient-education-intervention-in-an-open-health-system","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:59:55Z","timestamp":1770224395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421691-closing-the-osteoporosis-care-gap-system-level-fracture-liaison-service-implementation-and-a-patient-education-intervention-in-an-open-health-system"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.102971","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}